Intranasal Drug and Vaccine Delivery Market, By Product Type (Nasal Drops and Nasal Sprays), By Application (Vaccination, Pain Management, Respiratory Disorders, and Others), By End-user (Hospitals, ...

A company that’s poised to disrupt the nasal drug delivery market has signed a licensing deal with Avanir Pharmaceuticals (Nasdaq: AVNR) valued at $110 million. OptiNose’s drug delivery system in ...

Research by Wake Forest University School of Medicine provides a crucial method for future Alzheimer’s disease treatment trials and reveals key differences in how the drug is absorbed in people with ...

VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC:BLEG), a leader in innovative addiction treatment and harm reduction solutions, today announced that ...

Polyrizon Ltd., a biotechnology company focused on intranasal drug delivery systems, has reported promising preclinical results for its hydrogel-based Trap & Target (T&T) platform, developed in ...

NeOnc, a biotech company helmed by Dr. Thomas Chen, brings the first non-invasive intranasal drug delivery for brain cancer into the spotlight. With this revolutionary treatment, NeOnc is poised to ...

Ra’anana, Israel, June 12, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (PLRZ) (the “Company” or “Polyrizon”), a biotechnology company developing intranasal drug delivery systems, today announced ...

This collaboration reinforces Aptar’s position as a trusted partner in the evolving landscape of nasal vaccine delivery systems and next-generation vaccines. By leveraging its deep expertise in ...

(MENAFN- EIN Presswire) EINPresswire/ -- Overview of the Market: The Global Intranasal Drug Delivery Market has emerged as one of the fastest-growing therapeutic administration segments, led by rising ...

WINSTON-SALEM, N.C., July 23, 2025 — A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new Alzheimer’s disease treatments: Intranasal ...